Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels
NCT05241262
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Mitochondrial Disease
Interventions
DRUG:
N-Acetylcysteine
Sponsor
Michio Hirano, MD
Collaborators
[object Object]